Brookdale Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Internal Medicine/Cardiology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
J Pain Symptom Manage. 2023 Feb;65(2):111-119. doi: 10.1016/j.jpainsymman.2022.10.011.
Although palliative care is guideline-indicated for patients with advanced heart failure (HF), the scarcity of a specialty-trained palliative care workforce demands better identification of patients who are most burdened by the disease.
We sought to identify latent subgroups with variations regarding symptom burden, functional status, and multimorbidity in an advanced HF population.
We performed a latent class analysis (LCA) of baseline data from a trial enrolling advanced HF patients. As LCA input variables, we chose indicators of HF severity, physical and psychological symptom burden, functional status, and the number of comorbidities.
Among 563 patients, two subgroups emerged from LCA, Class A (352 [62.5%]) and Class B (211 [37.5%]). Patients in Class A were less often classified as NYHA class III or IV (88.0% vs. 97.5%, < 0.001), as compared to Class B patients. Class A patients had fewer symptoms, fewer comorbidities, only 25.9% had impairments in activities of daily living (ADL), and virtually none suffered from clinically significant anxiety (0.4%) or depression (0.9%). In Class B, every patient reported more than three symptoms, almost all patients (92.6%) had some impairment in ADL, and nearly a third had anxiety (30.2%) or depression (28.3%). All-cause mortality after 12 months was higher in Class B, as compared to Class A (18.5% vs. 12.5%, = 0.047).
Among advanced HF patients, we identified a distinct subgroup characterized by a conjunction of high symptom burden, anxiety, depression, multimorbidity, and functional status impairment, which might profit particularly from palliative care interventions. J Pain Symptom Manage 2022;000:1-9.
尽管缓和医疗是指南推荐的用于治疗晚期心力衰竭(HF)患者的方法,但由于专业的缓和医疗人员短缺,因此需要更好地识别出那些受疾病负担最重的患者。
我们旨在确定在晚期 HF 患者人群中,在症状负担、功能状态和合并症方面存在差异的潜在亚组。
我们对一项纳入晚期 HF 患者的试验的基线数据进行了潜在类别分析(LCA)。作为 LCA 的输入变量,我们选择了 HF 严重程度、身体和心理症状负担、功能状态和合并症数量的指标。
在 563 名患者中,LCA 产生了两个亚组,A 类(352 名[62.5%])和 B 类(211 名[37.5%])。与 B 类患者相比,A 类患者较少被归类为 NYHA 心功能 III 或 IV 级(88.0% vs. 97.5%,<0.001)。A 类患者的症状较少,合并症较少,只有 25.9%的患者日常生活活动(ADL)受损,几乎没有人患有临床显著的焦虑(0.4%)或抑郁(0.9%)。在 B 类中,每个患者报告了超过三个症状,几乎所有患者(92.6%)在 ADL 方面都有一些受损,近三分之一的患者有焦虑(30.2%)或抑郁(28.3%)。与 A 类相比,B 类患者在 12 个月后的全因死亡率更高(18.5% vs. 12.5%,=0.047)。
在晚期 HF 患者中,我们确定了一个独特的亚组,其特征是高症状负担、焦虑、抑郁、合并症和功能状态受损的综合表现,这些患者可能特别受益于姑息治疗干预。